<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment</title>
    <link>https://www.taxtmi.com/news?id=29671</link>
    <description>SIRONA, a prospective, multi-center, core-lab adjudicated randomized controlled trial of 482 patients across 25 sites, found the MagicTouch sirolimus-coated balloon non-inferior to multiple paclitaxel-coated balloons for 1-year primary patency, with no significant difference in 12 month clinically-driven target lesion revascularization and similar functional improvements, supporting sirolimus as an alternative option for femoropopliteal PAD interventions.</description>
    <language>en-us</language>
    <pubDate>Tue, 07 Jan 2025 17:46:03 +0530</pubDate>
    <lastBuildDate>Tue, 07 Jan 2025 17:46:03 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=787063" rel="self" type="application/rss+xml"/>
    <item>
      <title>Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment</title>
      <link>https://www.taxtmi.com/news?id=29671</link>
      <description>SIRONA, a prospective, multi-center, core-lab adjudicated randomized controlled trial of 482 patients across 25 sites, found the MagicTouch sirolimus-coated balloon non-inferior to multiple paclitaxel-coated balloons for 1-year primary patency, with no significant difference in 12 month clinically-driven target lesion revascularization and similar functional improvements, supporting sirolimus as an alternative option for femoropopliteal PAD interventions.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Tue, 07 Jan 2025 17:46:03 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=29671</guid>
    </item>
  </channel>
</rss>